1,458
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Effect of functionalization on drug delivery potential of carbon nanotubes

, , &
Pages 1851-1860 | Received 30 Jul 2015, Accepted 13 Oct 2015, Published online: 06 Jan 2016

References

  • Das M, Datir SR, Singh RP, Jain S. 2013. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic acid-multiwalled carbon nanotube conjugate. Mol Pharm. 10:2543–2557.
  • Datsyuk V, Kalyva M, Papagelis K, Parthenios J, Tasis D, Siokou A, et al. 2008. Chemical oxidation of multiwalled carbon nanotubes. Carbon. 46:833–840.
  • Huang H, Yuan Q, Shah JS, Misra RD. 2011. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response. Adv Drug Deliv Rev. 63:1332–1339.
  • Iijima S. 1991. Helical microtubules of graphitic carbon. Nature. 354:56–58.
  • Jain AK, Dubey V, Mehra NK, Lodhi N, Nahar M, Mishra DK, et al. 2009. Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomedicine. 5:432–442.
  • Kayat J, Mehra NK, Gajbhiye V, Jain NK. 2015. Drug targeting to arthritic region via folic acid appended surface engineered multi-walled carbon nanotubes. J Drug Target. [Epub ahead of print]. doi:10.3109/1061186X.2015.1077846.
  • Li CC, Lin JL, Huang SJ, Lee JT, Chen CH. 2007. A new and acid-exclusive method for dispersing carbon multi-walled nanotubes in aqueous suspensions. Colloids Surf A Physicochem Eng Asp. 297:275–281.
  • Liu Z, Sun X, Nakayama-Ratchford N, Dai H. 2007. Supramolecular chemistry on on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 1:50–56.
  • Lodhi N, Mehra NK, Jain NK. 2013. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target. 21:67–76.
  • Mehra NK, Jain K, Jain NK. 2015a. Pharmaceutical and biomedical application of surface engineered carbon nanotubes. Drug Discov Today. 20:750–756.
  • Mehra NK, Jain NK. 2013. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. J Drug Target.21:745–758.
  • Mehra NK, Jain NK. 2015a. Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Colloids Surf B Biointerfaces. 132:17–26.
  • Mehra NK, Jain NK. 2015b. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting. J Drug Target. [Epub ahead of print]. doi:10.3109/1061186X.2015.1055571.
  • Mehra NK, Jain NK. 2015c. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery. Mol Pharm. 12:630–643.
  • Mehra NK, Verma AK, Mishra PR, Jain NK. 2014. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Biomaterials. 35:4573–4588.
  • Mittal V, Patel S, Sheth S. 2010. Development and characterization of folate targeted nanoparticle drug delivery system. Int J Pharm Bio Sci. 1:113.
  • Mo Y, Wang H, Liu J, Lan Y, Guo R, Zhang Y, et al. 2015. Controlled release and targeted delivery to cancer cells of doxorubicin from polysaccharide-functionalized single-walled carbon nanotubes. J Mater Chem B. 3:1846–1855.
  • Niu L, Meng L, Lu Q. 2013. Folate conjugated PEG on single walled carbon nanotubes for targeting delivery of doxorubicin to cancer cells. Macromol Biosci. 13:735–744.
  • Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z, et al. 2012. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials. 33:3324–3333.
  • Sharma P, Mehra NK, Jain K, Jain NK. 2015. Biomedical applications of carbon nanotubes: a critical review. Curr Drug Deliv. 12. PMID:26201344.
  • Shi X, Wang SH, Shen M, Antwerp ME, Chen X, Li C, et al. 2009. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging. Biomacromolecules. 10:1744–1750.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.